Blood lead levels, ALAD gene polymorphisms, and mortality - Wikidata - wikimedia - TriplyDB

Blood lead levels, ALAD gene polymorphisms, and mortality

Blood lead levels, ALAD gene polymorphisms, and mortality

http://www.wikidata.org/entity/Q28396502

about

Lead toxicity Lead exposure in US worksites: A literature review and development of an occupational lead exposure database from the published literature Blood Lead Levels and Cause-Specific Mortality of Inorganic Lead-Exposed Workers in South Korea Trends and variability in blood lead concentrations among US adults aged 20-64 years and senior citizens aged ≥65 years.Trends and variability in blood lead concentrations among US children and adolescents.ALAD genotypes and blood lead levels of neonates and children from e-waste exposure in Guiyu, China.Using threshold regression to analyze survival data from complex surveys: With application to mortality linked NHANES III Phase II genetic data.Delta-amino-levulinic acid dehydratase gene and essential tremor.Influence of delta-aminolevulinic acid dehydratase gene polymorphism on selected lead exposure biomarkers in a cohort of ex-smelter workers.

P2860

Q26799381-20685814-54AD-49C1-909A-0A90149062B0 Q28383979-2F06641A-D1A5-483E-9619-E832B47CBA87 Q28391274-3E51BF0D-E186-4D56-B61E-9047651B7A07 Q39864243-05D13963-A50D-4A47-ACEC-E9FDA2E65464 Q40116623-2705C10E-A19F-4BF6-B4F9-8B298BB5C28F Q42228672-6F0B3C3C-054A-4B4D-B4FC-078257E7C0A4 Q47293190-AB733AA9-F202-4233-841B-9BA6134ED375 Q50213916-2C0B8EE0-E212-4EFF-A8CF-22EFD849DA0F Q54701607-74E1EC61-BD61-42A3-9831-A9FBAC00A75F

P2860

Blood lead levels, ALAD gene polymorphisms, and mortality

http://www.wikidata.org/entity/Q28396502

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Blood lead levels, ALAD gene polymorphisms, and mortality

@ast

Blood lead levels, ALAD gene polymorphisms, and mortality

@en

Blood lead levels, ALAD gene polymorphisms, and mortality

@nl

type

label

Blood lead levels, ALAD gene polymorphisms, and mortality

@ast

Blood lead levels, ALAD gene polymorphisms, and mortality

@en

Blood lead levels, ALAD gene polymorphisms, and mortality

@nl

prefLabel

Blood lead levels, ALAD gene polymorphisms, and mortality

@ast

Blood lead levels, ALAD gene polymorphisms, and mortality

@en

Blood lead levels, ALAD gene polymorphisms, and mortality

@nl

P1433

Q28396502-C40D75D9-FF08-45CC-A096-BD8C32F828AE

P1476

Q28396502-B7EEB794-A25A-4043-A61D-ECC2752F1BDF

P2093

Q28396502-37C107C9-2D36-467A-8524-D84D8846C878

Q28396502-47770C5F-51CF-48A0-824C-C1C5661F8127

Q28396502-48610E90-9F88-4009-A718-D261CB78C983

Q28396502-49EB32E0-2631-46EE-8743-EC529B5F18F1

Q28396502-6208D2D4-F8AD-4DE3-917E-8347C620BA12

Q28396502-BE49AF4C-CEBD-4A22-9AE4-F2162CACBAB2

Q28396502-F42BFA38-C92D-43A6-89F9-5C4E0FE2208B

P2860

Q28396502-008129A3-6DF4-4A52-A5D9-CF7BD850AD76

Q28396502-19019292-451F-4A35-931C-0F5977CAD078

Q28396502-25B1E94E-DB47-42D3-8383-A27013A4D375

Q28396502-273FBC89-CEE0-45AE-9D5F-EDD351806C74

Q28396502-2B0F7435-9BB4-4169-9E6D-4058B939B2B1

Q28396502-36795FF4-280C-4168-8DB2-ED81609F51D6

Q28396502-36A8E0DF-10A5-42A8-850B-E39AE7220015

Q28396502-432EC029-C2AB-473E-B977-28123028EA67

Q28396502-4591FA6C-D77E-4E6B-BB64-5DD833EBB997

Q28396502-49B75AAE-E4DD-45BA-9416-CE0D5CDC4A09

P304

Q28396502-07602B23-4F78-4F7B-8D97-802F394D0694

P31

Q28396502-066C24A8-D319-4B4E-AB87-29BCF7733790

P356

Q28396502-1100353A-DF5B-42CC-97E6-10356C0D7825

P407

Q28396502-C6E154E0-FE53-48D7-BBB5-ED6205112803

P433

Q28396502-F3A327F1-E7BD-4AC4-8408-F32C4BE559AE

P478

Q28396502-30CD334C-F12E-4574-A2B3-61FF92DB4EB8

P577

Q28396502-4B9984AA-8462-44A3-AB57-F856C99C029B

P698

Q28396502-D548BB5F-65DA-4AEC-A39A-9C28B6EBF3DE

P932

Q28396502-DCD0CE30-68B2-4367-9D07-19D63B870696

P356

EDE.0B013E3182093F75

P1433

P1476

Blood lead levels, ALAD gene polymorphisms, and mortality

@en

P2093

Barry Graubard

http://www.w3.org/2001/XMLSchema#string

Dana M van Bemmel

http://www.w3.org/2001/XMLSchema#string

Jody McLean

http://www.w3.org/2001/XMLSchema#string

Man-Huei Chang

http://www.w3.org/2001/XMLSchema#string

Nicole F Dowling

http://www.w3.org/2001/XMLSchema#string

Preetha Rajaraman

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence in the United States of selected candidate gene variants. Third National Health and Nutrition Examination Survey, 1991- 1994

Lead, genetic susceptibility, and risk of adult brain tumors

Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning

Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.

The association of blood lead level and cancer mortality among whites in the United States.

Interpreting and managing blood lead levels <10 µg/dL in children and reducing childhood exposures to lead: recommendations of CDC's Advisory Committee on Childhood Lead Poisoning Prevention

Genetic susceptibility to lead poisoning

Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis

240-kDa proteasome inhibitor (CF-2) is identical to delta-aminolevulinic acid dehydratase

The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES)

P304

273-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/EDE.0B013E3182093F75

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21293208

http://www.w3.org/2001/XMLSchema#string

P932

3932657

http://www.w3.org/2001/XMLSchema#string